Agrenvec
PrivateLast Round
Grant
Feb 26, 2025
Total Funding Raised
$1.26M
Company Overview
Agrenvec is a biotechnology company that specializes in the plant-based manufacturing of high-quality recombinant human proteins for skincare, diagnostics, research, and biotechnological applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agrenvec Comparables
Compare Agrenvec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leaf Expression Systems | 88% | |
| ORF Genetics | 88% | |
| Cape Bio Pharms | 86% | |
Agrenvec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 26, 2025 | ||||
| Grant | Dec 30, 2022 | ||||
| Series A | Apr 27, 2010 |
Agrenvec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AXIS Participaciones Empresariales | Series A |
| European Union NextGenerationEU | Grant |
| Criteria Capital Risc | Series A |
| Center for Technological Development and Innovation | Grant |
Agrenvec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Agrenvec's valuation, stock price, and market status.